July 2019 newsletter
The importance of understanding protein-protein and protein-ligand interactions in immuno-oncology Immuno-oncology represents a new paradigm in the fight against cancer and ...
The latest version of Blaze™, our virtual screening platform is now available. V10.3 introduces pharmacophore constraints to enable you to find the best possible new hits and leads. Alongside pharmacophore constraints, we’ve added additional similarity metrics and updated the user interface.
New versions (V10.5) of Forge™ and Torch™ are due out next month. This release offers new science and functionality and plenty of improvements that significantly enhance both applications. Here we offer a sneak peek at some of the new functionality in Forge.
What does Flare™, our new structure-based design application, offer Cresset Discovery Services that it didn’t have before?
Up to 25% off academic research licenses on all orders received by October 31, 2017.
On October 1, 2017, David Bardsley, our Commercial Director will run his 32nd half marathon in Cardiff, UK. We’re delighted to sponsor David in raising funds for cancer research at Cardiff University.